Advertisement
Screener

TETRAPHASE PHARMACEUTICALS INC Net Income

TETRAPHASE PHARMACEUTICALS INC Net Income

TETRAPHASE PHARMACEUTICALS INC reported Net Income of -$12.12 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2020-05-07

  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2020-03-31 was -$12.12M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2019-12-31 was -$11.37M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2019-09-30 was -$16.30M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2019-06-30 was -$22.92M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2019 was -$70.08M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2018 was -$72.16M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2017 was -$114.75M.
  • TETRAPHASE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2016 was -$77.48M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 81 monthNet Income (Loss) Attributable to Parent 84 monthNet Income (Loss) Attributable to Parent 87 monthNet Income (Loss) Attributable to Parent 90 monthNet Income (Loss) Attributable to Parent 93 month
2020-03-31-$12.12M
10-Q · filed 2020-05-07
-$23.50M
derived: sum of 2 quarters · filed 2020-05-07
-$39.80M
derived: sum of 3 quarters · filed 2020-05-07
-$62.72M
derived: sum of 4 quarters · filed 2020-05-07
2019-12-31-$11.37M
10-K · filed 2020-03-12
-$27.68M
derived: sum of 2 quarters · filed 2020-03-12
-$50.60M
derived: sum of 3 quarters · filed 2020-03-12
-$70.08M
10-K · filed 2020-03-12
2019-09-30-$16.30M
10-K · filed 2020-03-12
-$39.23M
derived: sum of 2 quarters · filed 2020-03-12
-$58.71M
10-Q · filed 2019-11-12
-$80.19M
derived: sum of 4 quarters · filed 2020-05-07
2019-06-30-$22.92M
10-K · filed 2020-03-12
-$42.41M
10-Q · filed 2019-08-08
-$63.89M
derived: sum of 3 quarters · filed 2020-05-07
-$83.45M
derived: sum of 4 quarters · filed 2020-05-07
2019-03-31-$19.49M
10-Q · filed 2020-05-07
-$40.97M
derived: sum of 2 quarters · filed 2020-05-07
-$60.53M
derived: sum of 3 quarters · filed 2020-05-07
-$70.07M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$21.48M
10-K · filed 2020-03-12
-$41.04M
derived: sum of 2 quarters · filed 2020-03-12
-$50.58M
derived: sum of 3 quarters · filed 2020-03-12
-$72.16M
10-K · filed 2020-03-12
2018-09-30-$19.56M
10-K · filed 2020-03-12
-$29.10M
derived: sum of 2 quarters · filed 2020-03-12
-$50.68M
10-Q · filed 2019-11-12
-$74.15M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$9.54M
10-K · filed 2020-03-12
-$31.12M
10-Q · filed 2019-08-08
-$54.59M
derived: sum of 3 quarters · filed 2020-03-12
-$84.60M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$21.58M
10-K · filed 2020-03-12
-$45.05M
derived: sum of 2 quarters · filed 2020-03-12
-$75.06M
derived: sum of 3 quarters · filed 2020-03-12
-$106.87M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$23.48M
10-K · filed 2019-03-15
-$53.48M
derived: sum of 2 quarters · filed 2019-03-15
-$85.29M
derived: sum of 3 quarters · filed 2019-03-15
-$114.75M
10-K · filed 2019-03-15
2017-09-30-$30.01M
10-K · filed 2019-03-15
-$61.82M
derived: sum of 2 quarters · filed 2019-03-15
-$91.28M
10-Q · filed 2018-11-09
-$113.74M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$31.81M
10-K · filed 2019-03-15
-$61.27M
10-Q · filed 2018-08-02
-$83.73M
derived: sum of 3 quarters · filed 2019-03-15
-$104.84M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31-$29.46M
10-K · filed 2019-03-15
-$51.92M
derived: sum of 2 quarters · filed 2019-03-15
-$73.03M
derived: sum of 3 quarters · filed 2019-03-15
-$90.20M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$22.46M
10-K · filed 2018-03-06
-$43.57M
derived: sum of 2 quarters · filed 2018-03-06
-$60.74M
derived: sum of 3 quarters · filed 2018-03-06
-$77.48M
10-K · filed 2018-03-06
2016-09-30-$21.11M
10-K · filed 2018-03-06
-$38.28M
derived: sum of 2 quarters · filed 2018-03-06
-$55.02M
10-Q · filed 2017-11-01
-$73.14M
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30-$17.17M
10-K · filed 2018-03-06
-$33.91M
10-Q · filed 2017-08-02
-$52.02M
derived: sum of 3 quarters · filed 2018-03-06
-$70.07M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31-$16.74M
10-K · filed 2018-03-06
-$34.86M
derived: sum of 2 quarters · filed 2018-03-06
-$52.90M
derived: sum of 3 quarters · filed 2018-03-06
-$78.94M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31-$18.12M
10-K · filed 2017-03-13
-$36.16M
derived: sum of 2 quarters · filed 2017-03-13
-$62.20M
derived: sum of 3 quarters · filed 2017-03-13
-$83.19M
10-K · filed 2018-03-06
2015-09-30-$18.04M
10-K · filed 2017-03-13
-$44.09M
derived: sum of 2 quarters · filed 2017-03-13
-$65.07M
10-Q · filed 2016-11-03
-$85.62M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$26.04M
10-K · filed 2017-03-13
-$47.03M
10-Q · filed 2016-08-04
-$67.58M
derived: sum of 3 quarters · filed 2017-03-13
-$81.78M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31-$20.99M
10-K · filed 2017-03-13
-$41.54M
derived: sum of 2 quarters · filed 2017-03-13
-$55.74M
derived: sum of 3 quarters · filed 2017-03-13
-$74.20M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$20.55M
10-K · filed 2016-02-25
-$34.76M
derived: sum of 2 quarters · filed 2016-02-25
-$53.22M
derived: sum of 3 quarters · filed 2016-02-25
-$66.74M
10-K · filed 2017-03-13
2014-09-30-$14.21M
10-K · filed 2016-02-25
-$32.67M
derived: sum of 2 quarters · filed 2016-02-25
-$46.19M
10-Q · filed 2015-11-02
-$57.49M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$18.46M
10-K · filed 2016-02-25
-$31.99M
10-Q · filed 2015-08-06
-$43.29M
derived: sum of 3 quarters · filed 2016-02-25
-$53.41M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$13.52M
10-K · filed 2016-02-25
-$24.83M
derived: sum of 2 quarters · filed 2016-02-25
-$34.94M
derived: sum of 3 quarters · filed 2016-02-25
-$40.37M
derived: sum of 4 quarters · filed 2016-02-25
-$133.24M
10-Q · filed 2014-05-12
2013-12-31-$11.30M
10-K · filed 2015-03-06
-$21.42M
derived: sum of 2 quarters · filed 2015-03-06
-$26.84M
derived: sum of 3 quarters · filed 2015-03-06
-$29.64M
10-K · filed 2016-02-25
-$119.72M
10-K · filed 2014-03-06
2013-09-30-$10.12M
10-K · filed 2015-03-06
-$15.54M
derived: sum of 2 quarters · filed 2015-03-06
-$18.33M
10-Q · filed 2014-11-10
-$21.39M
derived: sum of 4 quarters · filed 2015-03-06
-$108.42M
10-Q · filed 2013-11-14
2013-06-30-$5.43M
10-K · filed 2015-03-06
-$8.22M
10-Q · filed 2014-08-12
-$11.27M
derived: sum of 3 quarters · filed 2015-03-06
-$14.35M
derived: sum of 4 quarters · filed 2015-03-06
-$98.30M
10-Q · filed 2013-08-12
2013-03-31-$2.79M
10-K · filed 2015-03-06
-$5.84M
derived: sum of 2 quarters · filed 2015-03-06
-$8.92M
derived: sum of 3 quarters · filed 2015-03-06
-$13.19M
derived: sum of 4 quarters · filed 2015-03-06
-$92.88M
10-Q · filed 2013-05-13
2012-12-31-$3.05M
10-K · filed 2014-03-06
-$6.13M
derived: sum of 2 quarters · filed 2014-03-06
-$10.40M
derived: sum of 3 quarters · filed 2014-03-06
-$15.09M
10-K · filed 2015-03-06
2012-09-30-$3.08M
10-K · filed 2014-03-06
-$7.35M
derived: sum of 2 quarters · filed 2014-03-06
-$12.04M
10-Q · filed 2013-11-14
2012-06-30-$4.27M
10-K · filed 2014-03-06
-$8.96M
10-Q · filed 2013-08-12
2012-03-31-$4.69M
10-K · filed 2014-03-06
2011-12-31-$21.56M
10-K · filed 2014-03-06
2010-12-31-$17.48M
10-K · filed 2014-03-06
2009-12-31-$14.91M
10-K · filed 2014-03-06
2008-12-31-$12.76M
10-K · filed 2014-03-06
2007-12-31-$7.07M
10-K · filed 2014-03-06
2006-12-31-$1.22M
10-K · filed 2014-03-06